← Back to Search

Other

Cutaneous Biopsy for microarray analysis for Melanoma (RATIO Trial)

N/A
Waitlist Available
Led By Michael Smylie, MB, FRCPC
Research Sponsored by AHS Cancer Control Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

RATIO Trial Summary

This study is evaluating whether a new diagnostic system can detect melanoma in biopsies.

Eligible Conditions
  • Melanoma

RATIO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of the MMDx from pretreatment biopsy with overall response rate (ORR).
Secondary outcome measures
Overall Survival (OS)
Progression Free Survival (PFS)

RATIO Trial Design

1Treatment groups
Experimental Treatment
Group I: Cutaneous Biopsy for microarray analysisExperimental Treatment1 Intervention
To determine whether outcomes improve as a function of anti-tumor immunity which may enable the use of this technique as a predictive biomarker of treatment response.

Find a Location

Who is running the clinical trial?

Transplant Genomics, Inc.Industry Sponsor
13 Previous Clinical Trials
3,965 Total Patients Enrolled
AHS Cancer Control AlbertaLead Sponsor
182 Previous Clinical Trials
36,177 Total Patients Enrolled
1 Trials studying Melanoma
11 Patients Enrolled for Melanoma
Michael Smylie, MB, FRCPCPrincipal InvestigatorAlberta Health services

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
RATIO: Rational Approach To Immuno-Oncology
2016. "RATIO: Rational Approach To Immuno-Oncology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02700971.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top